Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Northside Hospital, Inc.
Thomas Jefferson University
City of Hope Medical Center
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Gilead Sciences
M.D. Anderson Cancer Center
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
European Myeloma Network B.V.
Masonic Cancer Center, University of Minnesota
Dana-Farber Cancer Institute
University of California, San Francisco
Medical College of Wisconsin
Celgene
National Institutes of Health Clinical Center (CC)
Massachusetts General Hospital
University of California, San Francisco
Essen Biotech
M.D. Anderson Cancer Center
Senti Biosciences
Juno Therapeutics, a Subsidiary of Celgene
Mayo Clinic
Medical College of Wisconsin
M.D. Anderson Cancer Center
Fate Therapeutics
Thomas Jefferson University
University of Rochester
National Institutes of Health Clinical Center (CC)
Caribou Biosciences, Inc.
Case Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
University of Pennsylvania
Indapta Therapeutics, INC.
Cartesian Therapeutics
Janssen Scientific Affairs, LLC
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Cedars-Sinai Medical Center
Cartesian Therapeutics
Allogene Therapeutics
The First Affiliated Hospital with Nanjing Medical University
Jonsson Comprehensive Cancer Center
Gilead Sciences
Fred Hutchinson Cancer Center
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Gilead Sciences